logo

Amgen Inc. (AMGN)



Trade AMGN now with
  Date
  Headline
7/31/2017 9:11:37 AM Amgen Submits SBLA Or Prolia (denosumab) In Glucocorticoid-Induced Osteoporosis
7/31/2017 9:03:10 AM Amgen And Allergan Submit Biosimilar Biologics License Application For ABP 980 To FDA
7/28/2017 4:03:32 PM Amgen Declares Q3 Dividend Of $1.15, Payable Sept. 8/ Record Aug. 17
7/28/2017 4:03:00 PM Amgen Inc. (AMGN) Declares $ 1.15 Dividend for Q3 17, Record Date 8/17/2017
7/27/2017 5:51:44 PM Amgen: FDA Grants Priority Review For SBLA For Repatha (evolocumab), A PCSK9 Inhibitor
7/25/2017 5:07:58 PM Amgen Inc. (AMGN) Has Raised Its 2017 Revenue Estimate To $22.5 - $23.0 Bln From $22.3 - $23.1 Bln
7/25/2017 5:06:54 PM Amgen Inc. (AMGN) Has Raised Its 2017 EPS Estimate To 12.15 - 12.65 From 12.00 - 12.60
7/25/2017 4:02:58 PM Amgen Q2 EPS $2.91 Vs. $2.47 Year Ago
7/20/2017 4:33:27 PM Amgen Says FDA Accepts Biologics License Application For Aimovig (erenumab)
7/18/2017 8:04:39 AM Amgen, Array BioPharma Collaborate For Discovery And Development Of Novel Drugs For Autoimmune Disorders